Skip to main content

Table 2 Levels of inflammageing markers differ between age groups

From: Frailty is related to serum inflammageing markers: results from the VITAL study

Median (IQR)

Unit

Total

Young

Middle- age

Older

N

Ā 

317

63

95

159

ā€ƒGroup a

ā€ƒIL-6

pg/mL

0.89 (0.46ā€“1.37)

0.40 (0.22ā€“0.84)

0.69 (0.43ā€“1.12)

1.10 (0.72ā€“1.74)

ā€ƒElastase

ng/mL

208 (153ā€“296)

175 (128ā€“220)

195 (154ā€“271)

228 (166ā€“338)

ā€ƒsCD163

ng/mL

745 (518ā€“1134)

529 (381ā€“547)

681 (530ā€“1039)

906 (627ā€“1244)

ā€ƒCXCL10 (IP-10)

pg/mL

24.7 (18.8ā€“31.7)

18.8 (14.7ā€“23.2)

21.2 (17.5ā€“28.5)

29.1 (22.1ā€“35.4)

ā€ƒYKL-40

ng/mL

37.6 (26.0ā€“67.7)

24.3 (19.7ā€“31.2)

30.3 (22.0ā€“42.9)

58.2 (35.8ā€“93.6)

ā€ƒNeopterin

nmol/L

8.47 (5.74ā€“11.33)

5.78 (4.11ā€“8.01)

7.65 (5.64ā€“9.72)

10.45 (7.13ā€“13.95)

Group b

ā€ƒCCL2

pg/mL

402 (317ā€“498)

335 (290ā€“416)

413 (319ā€“519)

417 (339ā€“523)

ā€ƒIL-8

pg/mL

20.5 (14.8ā€“34.1)

14.9 (11.5ā€“21.4)

20.5 (15.3ā€“42.6)

22.3 (16.4ā€“35.4)

ā€ƒsIL-6R

ng/mL

46.9 (41.3ā€“52.9)

42.8 (37.3ā€“49.6)

47.1 (41.3ā€“52.9)

48.4 (42.4ā€“53.8)

ā€ƒiFABP2

pg/mL

1138 (843ā€“1644)

908 (660ā€“1233)

1113 (863ā€“1507)

1235 (932ā€“1839)

ā€ƒsGP130

ng/mL

143 (131ā€“157)

134 (120ā€“145)

143 (130ā€“158)

147 (136ā€“158)

Group c

ā€ƒPR3

ng/mL

32.4 (24.5ā€“46.8)

27.9 (22.6ā€“38.6)

28.7 (19.9ā€“42.9)

37.9 (26.4ā€“52.7)

ā€ƒCRP

mg/L

1.19 (0.55ā€“2.82)

0.75 (0.23ā€“1.89)

1.00 (0.45ā€“2.29)

1.62 (0.68ā€“3.31)

ā€ƒsCD14

ng/mL

1446 (1252ā€“1645)

1327 (1129ā€“1533)

1418 (1229ā€“1573)

1661 (1135ā€“2254)

ā€ƒAngiopoietin-2

pg/mL

2023 (1593ā€“2742)

1787 (1268ā€“2545)

1909 (1545ā€“2319)

2233 (1749ā€“3000)

ā€ƒsCD25

pg/mL

522 (427ā€“653)

467 (381ā€“547)

478 (388ā€“61)

595 (488ā€“718)

ā€ƒIL-1RA

pg/mL

855 (670ā€“1106)

708 (567ā€“975)

770 (651ā€“992)

936 (779ā€“1245)

ā€ƒIFN-Ī³

pg/mL

0.04 (0.03ā€“0.07)

0.03 (0.02ā€“0.04)

0.04 (0.02ā€“0.06)

0.05 (0.03ā€“0.08)

ā€ƒSAA

ng/mL

135 (6ā€“735)

45 (5ā€“356)

67 (5ā€“356)

259 (39ā€“886)

Group d

ā€ƒCalprotectin

ng/mL

1586 (1102ā€“2310)

1538 (772ā€“2084)

1661 (1135ā€“2254)

1661 (1135ā€“2254)

ā€ƒC5a

ng/mL

21.3 (16ā€“28.6)

19.5 (15.6ā€“25.5)

19.6 (14.7ā€“28.7)

22.7 (16.9ā€“29.5)

ā€ƒPTX-3

pg/mL

5519 (4103ā€“7188)

5328 (3789ā€“6988)

5402 (4032ā€“6949)

5679 (4697ā€“7278)

ā€ƒCathepsin G

ng/mL

6.62 (4.70ā€“8.66)

6.48 (4.60ā€“8.04)

6.10 (4.65ā€“8.83)

7.20 (4.83ā€“8.77)

ā€ƒA1AT/elastase complex

Āµg/mL

56 (38ā€“96)

55 (9ā€“106)

73 (26ā€“135)

52 (39ā€“81)

ā€ƒGM-CSF

pg/mL

0.17 (0.13ā€“0.22)

0.17 (0.13ā€“0.23)

0.17 (0.12ā€“0.22)

0.18 (0.13ā€“0.22)

ā€ƒIL-1Ī²

pg/mL

0.03 (0.01ā€“0.-6)

0.02 (0.01ā€“0.05)

0.04 (0.02ā€“0.07)

0.03 (0.01ā€“0.06)

ā€ƒTNF-Ī±

pg/mL

2.22 (1.87ā€“2.68)

2.08 (1.72ā€“2.52)

2.31 (1.81ā€“2.68)

2.21 (1.81ā€“2.68)

ā€ƒIL-10

pg/mL

0.57 (0.42ā€“0.83)

0.50 (0.38ā€“0.68)

0.66 (0.45ā€“0.86)

0.56 (0.40ā€“0.84)

ā€ƒIFN-Ī±

pg/mL

0.01 (0.01ā€“0.02)

0.01 (0.01ā€“0.02)

0.01 (0.00ā€“0.02)

0.01 (0.01ā€“0.02)

  1. Markers are sorted per group depending on the pattern as seen in Fig. 2. Shown is medianā€‰Ā±ā€‰IQR. IQR inter-quartile range